Consensus Alkem Laboratories Limited

Stocks

ALKEM

INE540L01014

Pharmaceuticals

Market Closed - NSE India S.E. 07:05:06 2026-10-13 EDT			5-day change	1st Jan Change
5,250.00 ^INR	+0.86%		+1.11%	-4.66%

09-24	Alkem Laboratories Limited Announces Resignation of Nitin Agrawal as Chief Financial Officer	CI
09-24	Alkem Laboratories Limited Announces Resignation of Nitin Agrawal as Key Managerial Personnel and Senior Management Personnel, Effective September 30, 2026	CI

Evolution of the Average Target: Alkem Laboratories Limited

Evolution of the Target Price: Alkem Laboratories Limited

Changes in Analyst Recommendations: Alkem Laboratories Limited

d91924202e934d9c.T3M7ljBS9gxf43GhYTGEJcZNh0g6PgoVic-y6U4YGsA.GT0Jz3IAgHhylRuZC0fgR6kowy8NTTJ32YrfogNbdJh3GEOkfiGseTWORQ~6a9cdf0ab3bba4bbdb1e0a76489d49f6

Analysts' recommendations: Alkem Laboratories Limited

05-29	Bob Capital Markets Downgrades Alkem Laboratories to Sell From Hold; Price Target is INR4,638	MT
05-29	Jefferies Adjusts Alkem Laboratories' Price Target to INR6,500 From INR6,550, Keeps at Buy	MT
02-16	Nomura Adjusts Alkem Laboratories' Price Target to INR6,890 From INR 6,860, Keeps at Buy	MT
02-16	IIFL Upgrades Alkem Laboratories to Buy from Add, Price Target is INR6,300	MT
11-17	Nomura Adjusts Alkem Laboratories' Price Target to INR6,860 From INR6,300, Keeps at Buy	MT
25-08-22	Nomura Adjusts Alkem Laboratories' Price Target to INR6,300 From INR5,430, Keeps at Buy	MT
25-08-13	Jefferies Upgrades Alkem Laboratories to Buy From Underperform, Adjusts Price Target to INR6,000 From INR4,460	MT
25-05-30	Jefferies Adjusts Alkem Laboratories' Price Target to INR4,460 From INR4,580, Keeps at Underperform	MT
25-02-27	Nomura Upgrades Alkem Laboratories to Buy From Neutral, Adjusts Price Target to INR5,430 From INR5,670	MT
25-02-10	Nomura Adjusts Alkem Laboratories' Price Target to INR5,670 From INR6,097, Keeps at Neutral	MT
25-02-10	Jefferies Adjusts Alkem Laboratories' Price Target to INR4,580 From INR5,080, Keeps at Underperform	MT
24-11-15	Nomura Adjusts Alkem Laboratories' Price Target to INR6,097 From INR6,061, Keeps at Neutral	MT
24-11-14	Jefferies Adjusts Alkem Laboratories' Price Target to INR4,950 From INR5,080, Keeps at Underperform	MT
24-08-14	Nomura Adjusts Alkem Laboratories' Price Target to INR6,061 From INR5,605, Keeps at Neutral	MT
24-08-12	Jefferies Adjusts Alkem Laboratories' Price Target to INR5,080 From INR4,200, Keeps at Underperform	MT
24-05-30	Jefferies Adjusts Alkem Laboratories’ Price Target to INR4,200 From INR4,470, Keeps at Underperform	MT
24-02-12	Jefferies Adjusts Alkem Laboratories’ Price Target to INR4,470 From INR3,960, Keeps at Underperform	MT
23-11-09	Nomura Upgrades Alkem Laboratories to Buy From Neutral, Adjusts Price Target to INR4,963 From INR3,632	MT
23-11-08	Jefferies Adjusts Alkem Laboratories’ Price Target to INR3,600 From INR3,550, Keeps at Underperform	MT
23-08-11	Jefferies Adjusts Alkem Laboratories' Price Target to INR3,550 From INR2,800, Keeps at Underperform	MT
23-05-23	Nomura Downgrades Alkem Laboratories to Neutral From Buy, Adjusts Price Target to INR3,632 From INR3,772	MT
23-02-14	Nomura Adjusts Alkem Laboratories' Price Target to INR3,772 From INR3,602, Keeps at Buy	MT
23-02-13	Jefferies Adjusts Alkem Laboratories' Price Target to INR2,800 From INR2,600, Keeps at Underperform	MT
23-01-10	Nomura Upgrades Alkem Laboratories to Buy From Neutral, Adjusts Price Target to INR3,602 From INR3,487	MT

More recommendations

Other Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ALKEM LABORATORIES LIMITED					+15.32%
	ELI LILLY AND COMPANY					+12.47%
	JOHNSON & JOHNSON					+6.1%
	ABBVIE INC.					+0.53%
	MERCK & CO., INC.					+9.07%
	ROCHE HOLDING AG					+4.79%
	NOVARTIS AG					+4.48%
	ASTRAZENECA PLC					+31.52%
	AMGEN INC.					-5.67%
	GILEAD SCIENCES, INC.					+6.11%
	Average					+8.47%
	Weighted average by Cap.					+8.13%